Toll Free Helpline (India): 1800 1234 070
Rest of World: +91-9810852116
Free Publication Certificate
Submit Manuscript
Journal code(s)
- E-ISSN Number: 2277-7695
- P-ISSN Number: 2349-8242
- CODEN Code: PIHNBQ
- ZDB-Number: 2663038-2
- IC Journal ID: 7725
Main Menu
Special Issue
Copyright Form
Identifier
Vol. 5, Issue 4 (2016)
Clinical efficacy of omega-3 polyunsaturated fatty acids and rosuvastatin in combination therapy for patients with psoriasis and metabolic syndrome
Author(s):
N Virstyuk, М Nykyforuk
N Virstyuk, М Nykyforuk
Abstract:
Based on the examination and treatment of 100 patients with moderate psoriasis associated with metabolic syndrome, it was established that the use of narrowband UVB-therapy combined with rosuvastatin and omega-3 polyunsaturated fatty acids in combination therapy contributes to the improvement of the efficacy of therapy for dermatosis, induces a long-term remission and improves the life quality of patients.
Based on the examination and treatment of 100 patients with moderate psoriasis associated with metabolic syndrome, it was established that the use of narrowband UVB-therapy combined with rosuvastatin and omega-3 polyunsaturated fatty acids in combination therapy contributes to the improvement of the efficacy of therapy for dermatosis, induces a long-term remission and improves the life quality of patients.
Pages: 90-92 | 1498 Views 111 Downloads
How to cite this article:
N Virstyuk, М Nykyforuk. Clinical efficacy of omega-3 polyunsaturated fatty acids and rosuvastatin in combination therapy for patients with psoriasis and metabolic syndrome. Pharma Innovation 2016;5(4):90-92.
Journal code(s)
- E-ISSN Number: 2277-7695
- P-ISSN Number: 2349-8242
- CODEN Code: PIHNBQ
- ZDB-Number: 2663038-2
- IC Journal ID: 7725
Main Menu
Special Issue
Copyright Form
Identifier
The Pharma Innovation Journal
